Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Author:
Funder
National Institutes of Health
National Cancer Institute
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference330 articles.
1. FDA approval of nusinersen for spinal muscular atrophy makes 2016 the year of splice modulating oligonucleotides;Aartsma-Rus;Nucleic Acid Therapeutics,2017
2. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy;Abedi-Gaballu;Applied Materials Today,2018
3. The recent progresses in shRNA-nanoparticle conjugate as a therapeutic approach;Acharya;Materials Science & Engineering. C, Materials for Biological Applications,2019
4. Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy;Ackermann;Amyloid,2012
5. Suppressing transthyretin production in mice, monkeys and humans using 2nd-generation antisense oligonucleotides;Ackermann;Amyloid,2016
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Binding Mechanism of Riboswitch to Natural Ligand Elucidated by McMD-Based Dynamic Docking Simulations;ACS Omega;2024-01-10
2. Types of RNA therapeutics;Progress in Molecular Biology and Translational Science;2024
3. Long Non-Coding RNAs (lncRNAs) in Heart Failure: A Comprehensive Review;Non-Coding RNA;2023-12-28
4. Delivery of nucleic acids using nanomaterials;Molecular Biomedicine;2023-12-14
5. Gene-editing technology, from macromolecule therapeutics to organ transplantation: Applications, limitations, and prospective uses;International Journal of Biological Macromolecules;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3